ResMed Inc: A Decade of Dominance, But Can It Last?

ResMed Inc’s stock price has skyrocketed over the past decade, leaving investors who took the plunge 10 years ago with a substantial windfall of over $51,000. But what’s behind this remarkable success story? A closer look at the company’s financials reveals a strong foundation, with net tangible asset backing per share increasing to a staggering $8.51 as of July 31st.

But don’t be fooled – ResMed’s stock price hasn’t reached its 52-week high, indicating some volatility in the market. A recent close price of around $284 is a far cry from its peak, and investors would do well to remember that even the most successful companies can experience a downturn.

So, is ResMed Inc still a safe bet for investors? The numbers suggest it is, but only time will tell if the company can maintain its momentum. Here are a few key takeaways to consider:

• Strong Financials: ResMed’s net tangible asset backing per share has increased to $8.51, a clear indication of the company’s financial health.
• Stable Stock Price: Despite some volatility, ResMed’s stock price has remained relatively stable, with a recent close price of around $284.
• Investment Opportunity: With a decade of dominance under its belt, ResMed Inc presents a compelling investment opportunity for those looking to get in on the action.

But don’t take our word for it – do your own research and make an informed decision. The market is unpredictable, and even the most successful companies can experience a downturn.